Greenway customers benefit from eliminating paper-based processes. Credit: Andrei_R / Shutterstock.com. Greenway Health and Moxe Health have partnered to automate the exchange of clinical data for ...

Starting next month, Mozilla will require Firefox extension developers to disclose whether their add-ons collect or share user data with third parties. The devs will ...

Oracle Health has launched its new Connection Hub, a tool designed to help U.S. healthcare providers manage and share patient data through a single console. The platform aims to simplify ...

Advances in MM management have improved survival, but challenges remain for patients progressing after three therapy lines. New therapies like CAR T-cell and bispecific antibodies require integration ...

NEW YORK – Personalized cancer firm Artera this week presented four studies on its multimodal artificial intelligence (MMAI) digital pathology-based risk stratification platform at the annual ...

Three oral presentations highlight sustained reduction in residual volume, airway patency, and improved quality of life, including in patients with incomplete fissures and regardless of disease ...

EAST PROVIDENCE, R.I. (WPRI) — Earlier this week, President Donald Trump indicated that using acetaminophen, commonly known by its brand name Tylenol, shouldn’t be used during a pregnancy and could ...

1 Scenic City Neurotherapy and Ketamine Center LLC, Chattanooga, TN, United States 2 RailRoad Valley Therapeutics LLC, Chattanooga, TN, United States In recent years, ketamine therapy has become ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

Moderna (MRNA) announced “positive” preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. “The data from an ...